Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 215.45
-0.80 (-0.37%)
At close: Oct 16, 2026
Hikal Market Cap
Hikal has a market cap or net worth of 26.57 billion as of October 16, 2026. It is the 18,688th most valuable company in the world and the 1,113th biggest in India. Its market cap has decreased by 11.03% in one year.
Market Cap
26.57B
Enterprise Value
33.27B
Revenue
17.35B
Global Rank
Country Rank
#1,113 India
PE Ratio
n/a
ChartMarket Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 26.57B, an increase of 1,857.34%. That is a compound annual growth rate of 12.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 26.57B | -5.05% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evonile Pharma | 47.83B |
| Gufic Biosciences | 41.10B |
| Unichem Laboratories | 36.62B |
| Kwality Pharmaceuticals | 34.41B |
| Shukra Pharmaceuticals | 29.35B |
| Fredun Pharmaceuticals | 24.01B |
| Venus Remedies | 20.91B |
| Syncom Formulations (India) | 20.25B |